Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Davis

Showing results (321-330 of 358) with videos related to

Pageof 36
Sort By:
Immunity|April 3, 2026
Multiplexed antigen panel analysis identifies B cell phenotype and receptor genetic contributions to antibody breadthOliver F Wirz, Prasanti Kotagiri, Emily Haraguchi, et al.
Nature Medicine|November 8, 2016
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccinationJiwon Lee, Daniel R Boutz, Veronika Chromikova, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid culturesAmeen A Salahudeen, Shannon S Choi, Arjun Rustagi, et al.
Allergy|July 21, 2024
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adultsMihir M Shah, Janice A Layhadi, Dennis E Hourcade, et al.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Mbio|June 25, 2020
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen RecognitionMichal Caspi Tal, Laughing Bear Torrez Dulgeroff, Lara Myers, et al.
Nature Nanotechnology|January 21, 2026
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogensLiming Zhao, Kyle L O'Donnell, Megha Dubey, et al.
Immunity|March 10, 2021
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discoveryShin-Heng Chiou, Diane Tseng, Alexandre Reuben, et al.
Pageof 36

Showing results (321-330 of 358) with videos related to

Sort By:
Pageof 36
Immunity|April 3, 2026
Multiplexed antigen panel analysis identifies B cell phenotype and receptor genetic contributions to antibody breadthOliver F Wirz, Prasanti Kotagiri, Emily Haraguchi, et al.
Nature Medicine|November 8, 2016
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccinationJiwon Lee, Daniel R Boutz, Veronika Chromikova, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid culturesAmeen A Salahudeen, Shannon S Choi, Arjun Rustagi, et al.
Allergy|July 21, 2024
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adultsMihir M Shah, Janice A Layhadi, Dennis E Hourcade, et al.
Science Translational Medicine|January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severitySaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine responseSaborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Mbio|June 25, 2020
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen RecognitionMichal Caspi Tal, Laughing Bear Torrez Dulgeroff, Lara Myers, et al.
Nature Nanotechnology|January 21, 2026
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogensLiming Zhao, Kyle L O'Donnell, Megha Dubey, et al.
Immunity|March 10, 2021
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discoveryShin-Heng Chiou, Diane Tseng, Alexandre Reuben, et al.
Pageof 36